"lymphocyte ratio" trang 5 - tải miễn phí từ tailieunhanh
Expansion of the Milan criteria without any sacrifice: Combination of the Hangzhou criteria with the pre-transplant platelet-tolymphocyte ratio

Expansion of the Milan criteria without any sacrifice: Combination of the Hangzhou criteria with the pre-transplant platelet-tolymphocyte ratio
8    41    1
A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: The C-reactive protein/albumin ratio

A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: The C-reactive protein/albumin ratio
11    23    1
Báo cáo y học:

Báo cáo y học: "Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care uni"
8    36    0
Báo cáo khoa học:

Báo cáo khoa học: "A pre-operative elevated neutrophil: lymphocyte ratio does not predict survival from oesophageal cancer resection"
10    49    0
Prognostic value of lymphocyte-monocyte ratio at diagnosis in Hodgkin lymphoma: A meta-analysis

Prognostic value of lymphocyte-monocyte ratio at diagnosis in Hodgkin lymphoma: A meta-analysis
12    83    0
Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ

Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ
9    92    0
The values of neutrophil-lymphocyte ratio and/or prostate-specific antigen in discriminating real Gleason score ≥ 7 prostate cancer from group of biopsybased Gleason score ≤ 6

The values of neutrophil-lymphocyte ratio and/or prostate-specific antigen in discriminating real Gleason score ≥ 7 prostate cancer from group of biopsybased Gleason score ≤ 6
8    31    1
A novel combined systemic inflammationbased score can predict survival of intermediate-to-advanced hepatocellular carcinoma patients undergoing transarterial chemoembolization

A novel combined systemic inflammationbased score can predict survival of intermediate-to-advanced hepatocellular carcinoma patients undergoing transarterial chemoembolization
9    39    1
Long-term outcomes and significance of preoperative lymphocyte-to-monocyte ratio as a prognostic indicator in patients with invasive pancreatic neoplasms after repeat pancreatectomy

Long-term outcomes and significance of preoperative lymphocyte-to-monocyte ratio as a prognostic indicator in patients with invasive pancreatic neoplasms after repeat pancreatectomy
9    38    1
Predictive value of gamma-glutamyl transpeptidase to lymphocyte count ratio in hepatocellular carcinoma patients with microvascular invasion

Predictive value of gamma-glutamyl transpeptidase to lymphocyte count ratio in hepatocellular carcinoma patients with microvascular invasion
9    46    1
New pre-treatment eosinophil-related ratios as prognostic biomarkers for survival outcomes in endometrial cancer

New pre-treatment eosinophil-related ratios as prognostic biomarkers for survival outcomes in endometrial cancer
9    60    1
Neutrophil-lymphocyte ratio as a predictor of oncologic outcomes in stage IVB, persistent, or recurrent cervical cancer patients treated by chemotherapy

Neutrophil-lymphocyte ratio as a predictor of oncologic outcomes in stage IVB, persistent, or recurrent cervical cancer patients treated by chemotherapy
10    58    1
Hematologic markers of distant metastases and poor prognosis in gynecological cancers

Hematologic markers of distant metastases and poor prognosis in gynecological cancers
8    36    1
Optimal cutoff of pretreatment neutrophilto-lymphocyte ratio in head and neck cancer patients: A meta-analysis and validation study

Optimal cutoff of pretreatment neutrophilto-lymphocyte ratio in head and neck cancer patients: A meta-analysis and validation study
9    64    1
Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and nonoropharyngeal patients

Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and nonoropharyngeal patients
13    43    1
Neutrophil count is associated with survival in localized prostate cancer

Neutrophil count is associated with survival in localized prostate cancer
8    33    1
Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): A retrospective review

Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): A retrospective review
7    63    1
Exploratory analysis of the neutrophil to lymphocyte ratio in patients with pulmonary arterial hypertension

Exploratory analysis of the neutrophil to lymphocyte ratio in patients with pulmonary arterial hypertension
9    33    1
High score of LDH plus dNLR predicts poor survival in patients with HER2- positive advanced breast cancer treated with trastuzumab emtansine

High score of LDH plus dNLR predicts poor survival in patients with HER2- positive advanced breast cancer treated with trastuzumab emtansine
13    36    3
Significance of the neutrophil-tolymphocyte ratio in predicting the response to neoadjuvant chemotherapy in extremity osteosarcoma: A multicentre retrospective study

Significance of the neutrophil-tolymphocyte ratio in predicting the response to neoadjuvant chemotherapy in extremity osteosarcoma: A multicentre retrospective study
7    53    3